These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33961013)

  • 1. Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study.
    Clifford RE; Harji D; Poynter L; Jackson R; Adams R; Fearnhead NS; Vimalachandran D;
    Br J Surg; 2021 Nov; 108(11):1270-1273. PubMed ID: 33961013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 on treatment modalities and short-term outcomes of rectal cancer following neoadjuvant chemoradiotherapy: a retrospective study.
    Dong DZ; Dong QS; Zhang FN; Li CL; Wang L; Li YH; Wang WH; Wu AW
    Br J Surg; 2021 Apr; 108(4):e164-e165. PubMed ID: 33793768
    [No Abstract]   [Full Text] [Related]  

  • 3. [Time interval between neoadjuvant radiochemotherapy and surgery in rectal cancer : No impact on the pathologic complete response rate?].
    Gani C; Zips D
    Strahlenther Onkol; 2017 Jan; 193(1):91-92. PubMed ID: 27904939
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiotherapy management of rectal cancer in the backdrop of the COVID pandemic.
    Lewis S; Talapatra K
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1320. PubMed ID: 33295140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
    Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
    Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Operative Morbidity and Mortality Following Total Neoadjuvant Therapy Versus Conventional Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Sutera P; Solomina J; Wegner RE; Abel S; Monga D; Finley G; McCormick J; Kirichenko AV
    J Gastrointest Cancer; 2021 Sep; 52(3):976-982. PubMed ID: 32936391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment approach in locally advanced rectal cancer during coronavirus (COVID-19) pandemic: long course or short course?
    De Felice F; Petrucciani N
    Colorectal Dis; 2020 Jun; 22(6):642-643. PubMed ID: 32237263
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study.
    Pucciarelli S; Del Bianco P; Efficace F; Serpentini S; Capirci C; De Paoli A; Amato A; Cuicchi D; Nitti D
    Ann Surg; 2011 Jan; 253(1):71-7. PubMed ID: 21135694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretherapeutic MRI for decision-making regarding selective neoadjuvant radiochemotherapy for rectal carcinoma: interim analysis of a multicentric prospective observational study.
    Ptok H; Ruppert R; Stassburg J; Maurer CA; Oberholzer K; Junginger T; Merkel S; Hermanek P
    J Magn Reson Imaging; 2013 May; 37(5):1122-8. PubMed ID: 23526771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus.
    Siavashpour Z; Taghizadeh-Hesary F; Rakhsha A
    J Gastrointest Cancer; 2020 Sep; 51(3):800-804. PubMed ID: 32656628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project.
    Pellino G; Alós R; Biondo S; Codina-Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; Cervantes A; García-Granero E;
    Eur J Surg Oncol; 2021 Feb; 47(2):276-284. PubMed ID: 32950316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Neoadjuvant Treatment on the Tumor Microenvironment in Rectal Cancer: Implications for Immune Activation and Therapy Response.
    Chen CC; Wu ML; Huang KC; Huang IP; Chung YL
    Clin Colorectal Cancer; 2020 Dec; 19(4):e164-e180. PubMed ID: 32387305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma.
    Topova L; Hellmich G; Puffer E; Schubert C; Christen N; Boldt T; Wiedemann B; Witzigmann H; Stelzner S
    Dis Colon Rectum; 2011 Apr; 54(4):401-11. PubMed ID: 21383559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insurance Status in Rectal Cancer is Associated With Age at Diagnosis and May be Associated With Overall Survival.
    Bridges LC; Honaker MD; Smith BE; Montgomery A
    Am Surg; 2021 Jan; 87(1):105-108. PubMed ID: 32833496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.
    Smith JJ; Wasserman I; Milgrom SA; Chow OS; Chen CT; Patil S; Goodman KA; Garcia-Aguilar J
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):924-930. PubMed ID: 28333014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.
    Li F; Nielsen G; Baran A; Hu J; Wallace D; Preslar M; Fleming F; Temple L; Dunne RF; Noel M; Hezel AF; Tejani MA
    Clin Colorectal Cancer; 2020 Sep; 19(3):e124-e128. PubMed ID: 32409226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to neoadjuvant therapy in patients with early age-of-onset rectal cancer.
    Steinhagen E; Shia J; Riedel E; Nash GM; Weiser MR; Temple LK; Paty PB; Guillem JG
    Dis Colon Rectum; 2013 Jan; 56(1):58-63. PubMed ID: 23222281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
    Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
    Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic pattern and new primary tumours after neoadjuvant therapy and surgery in rectal cancer.
    Frambach P; Pucciarelli S; Perin A; Zuin M; Toppan P; Maretto I; Urso EDL; Spolverato G
    Colorectal Dis; 2018 Dec; 20(12):O326-O334. PubMed ID: 30230157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.